Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers
PHASE3RecruitingINTERVENTIONAL
Enrollment
136
Participants
Timeline
Start Date
May 15, 2025
Primary Completion Date
May 15, 2027
Study Completion Date
May 20, 2027
Conditions
Gastrointestinal Cancers
Interventions
DRUG
Entecavir
anti hepatitis B virus
Trial Locations (1)
510060
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
All Listed Sponsors
lead
Sun Yat-sen University
OTHER
NCT06966232 - Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers | Biotech Hunter | Biotech Hunter